UA58330A - Способ лечения рецидивов трихомонадно-хламидийной урогенитальной микст-инфекции у мужчин - Google Patents
Способ лечения рецидивов трихомонадно-хламидийной урогенитальной микст-инфекции у мужчин Download PDFInfo
- Publication number
- UA58330A UA58330A UA2002119426A UA2002119426A UA58330A UA 58330 A UA58330 A UA 58330A UA 2002119426 A UA2002119426 A UA 2002119426A UA 2002119426 A UA2002119426 A UA 2002119426A UA 58330 A UA58330 A UA 58330A
- Authority
- UA
- Ukraine
- Prior art keywords
- days
- day
- prescribed
- infection
- stage
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 13
- 208000003322 Coinfection Diseases 0.000 title claims abstract description 8
- 241000606161 Chlamydia Species 0.000 title abstract description 6
- 241000224526 Trichomonas Species 0.000 title abstract description 3
- 230000000306 recurrent effect Effects 0.000 title abstract 2
- 239000006215 rectal suppository Substances 0.000 claims abstract description 9
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Chemical compound FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)COC3=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229960001699 ofloxacin Drugs 0.000 claims abstract description 6
- 238000011287 therapeutic dose Methods 0.000 claims abstract description 5
- 238000011282 treatment Methods 0.000 claims description 17
- -1 mefenamine sodium salt Chemical class 0.000 claims description 9
- YXIWHUQXZSMYRE-UHFFFAOYSA-N 1,3-benzothiazole-2-thiol Chemical compound C1=CC=C2SC(S)=NC2=C1 YXIWHUQXZSMYRE-UHFFFAOYSA-N 0.000 claims description 8
- BKUKXOMYGPYFJJ-UHFFFAOYSA-N 2-ethylsulfanyl-1h-benzimidazole;hydrobromide Chemical compound Br.C1=CC=C2NC(SCC)=NC2=C1 BKUKXOMYGPYFJJ-UHFFFAOYSA-N 0.000 claims description 5
- 229960000282 metronidazole Drugs 0.000 claims description 5
- 239000000829 suppository Substances 0.000 claims description 5
- 208000010362 Protozoan Infections Diseases 0.000 claims description 4
- 229960004082 doxycycline hydrochloride Drugs 0.000 claims description 4
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 claims description 4
- 150000004957 nitroimidazoles Chemical class 0.000 claims description 4
- PTNZGHXUZDHMIQ-UHFFFAOYSA-N 4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide;hydrochloride Chemical compound Cl.C1=CC=C2C(C)C(C(O)C3C(C(O)=C(C(N)=O)C(=O)C3N(C)C)(O)C3=O)C3=C(O)C2=C1O PTNZGHXUZDHMIQ-UHFFFAOYSA-N 0.000 claims description 3
- 229940058965 antiprotozoal agent against amoebiasis and other protozoal diseases nitroimidazole derivative Drugs 0.000 claims description 3
- 238000012961 medicinal therapy Methods 0.000 claims 1
- 238000012876 topography Methods 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 abstract description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract description 2
- UGCOPUIBNABIEP-UHFFFAOYSA-N 2-ethylsulfanyl-1h-benzimidazole Chemical group C1=CC=C2NC(SCC)=NC2=C1 UGCOPUIBNABIEP-UHFFFAOYSA-N 0.000 abstract 1
- 208000028172 protozoa infectious disease Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 5
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 208000019802 Sexually transmitted disease Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 210000003708 urethra Anatomy 0.000 description 3
- UPCOSYBELNEQAU-UHFFFAOYSA-L (2-decoxy-2-oxoethyl)-[2-[(2-decoxy-2-oxoethyl)-dimethylazaniumyl]ethyl]-dimethylazanium;dichloride Chemical compound [Cl-].[Cl-].CCCCCCCCCCOC(=O)C[N+](C)(C)CC[N+](C)(C)CC(=O)OCCCCCCCCCC UPCOSYBELNEQAU-UHFFFAOYSA-L 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 241001502500 Trichomonadida Species 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000005067 remediation Methods 0.000 description 2
- 206010006784 Burning sensation Diseases 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001857 anti-mycotic effect Effects 0.000 description 1
- 239000002543 antimycotic Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 229960004022 clotrimazole Drugs 0.000 description 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 238000007915 intraurethral administration Methods 0.000 description 1
- XJSFLOJWULLJQS-NGVXBBESSA-N josamycin Chemical compound CO[C@H]1[C@H](OC(C)=O)CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](N(C)C)[C@H](O[C@@H]2O[C@@H](C)[C@H](OC(=O)CC(C)C)[C@](C)(O)C2)[C@@H](C)O1 XJSFLOJWULLJQS-NGVXBBESSA-N 0.000 description 1
- 229960004144 josamycin Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- XBCXJKGHPABGSD-UHFFFAOYSA-N methyluracil Natural products CN1C=CC(=O)NC1=O XBCXJKGHPABGSD-UHFFFAOYSA-N 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Landscapes
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Способ лечения рецидивов трихомонадно-хламидийной урогенитальной микст-инфекции у мужчин путем назначения медикаментозной базисной и местной терапии состоит в том, что лечение проводят в два этапа. На первом этапе назначают производные нитроимидазола, например метронидазол, перорально в полуторной терапевтической дозе. Одновременно местно применяют ректальные суппозитории. После контроля санации протозойной инфекции на втором этапе последовательно назначают доксициклина гидрохлорид и офлоксацин перорально, эрбисол внутримышечно и бемитил в таблетках.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA2002119426A UA58330A (ru) | 2002-11-27 | 2002-11-27 | Способ лечения рецидивов трихомонадно-хламидийной урогенитальной микст-инфекции у мужчин |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA2002119426A UA58330A (ru) | 2002-11-27 | 2002-11-27 | Способ лечения рецидивов трихомонадно-хламидийной урогенитальной микст-инфекции у мужчин |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA58330A true UA58330A (ru) | 2003-07-15 |
Family
ID=74212101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA2002119426A UA58330A (ru) | 2002-11-27 | 2002-11-27 | Способ лечения рецидивов трихомонадно-хламидийной урогенитальной микст-инфекции у мужчин |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA58330A (ru) |
-
2002
- 2002-11-27 UA UA2002119426A patent/UA58330A/ru unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bartlik et al. | Psychostimulants apparently reverse sexual dysfunction secondary to selective serotonin re-uptake inhibitors | |
| JP4451930B2 (ja) | 一酸化窒素の生成を阻害するテトラサイクリン化合物の使用方法 | |
| Kellock et al. | Sexually acquired metronidazole-resistant trichomoniasis in a lesbian couple. | |
| Lister et al. | Comparison of azithromycin and doxycycline in the treatment of non-gonococcal urethritis in men | |
| RU2003125274A (ru) | Применение флумазенила в производстве лекарства для лечения алкогольной зависимости | |
| Judson et al. | Comparative study of ceftriaxone and aqueous procaine penicillin G in the treatment of uncomplicated gonorrhea in women | |
| UA58330A (ru) | Способ лечения рецидивов трихомонадно-хламидийной урогенитальной микст-инфекции у мужчин | |
| AU777508B2 (en) | Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate | |
| RU2445964C2 (ru) | Способ элиминации бактерий atopobium vaginae при лечении бактериального вагиноза | |
| Houang et al. | Successful treatment of four patients with recalcitrant vaginal trichomoniasis with a combination of zinc sulfate douche and metronidazole therapy | |
| Cohen | Single dose treatment of vaginal candidosis: comparison of clotrimazole and isoconazole. | |
| Ndinya-Achola et al. | Three day oral course of Augmentin to treat chancroid. | |
| UA58969A (ru) | Способ лечения рецидивов кандидозно-микоплазменной урогенитальной микст-инфекции у женщин | |
| Авезова | Methods for treatment of chronic generalized periodontitis (literature review) | |
| RU2236218C1 (ru) | Способ лечения больных хроническим простатитом | |
| RU2431489C1 (ru) | Способ лечения хронических воспалительных заболеваний толстого кишечника | |
| RU2003116855A (ru) | Способ лечения воспалительных процессов вульвы и влагалища | |
| RU2688231C1 (ru) | Способ лечения лептотрихоза ротовой полости | |
| RU2179849C2 (ru) | Способ лечения рецидивирующего генитального герпеса у женщин | |
| FIUMARA | Pharyngeal infection with Neisseria gonorrhoeae | |
| Braff | Amoxicillin in the treatment of gonorrhea | |
| Evans et al. | Sulphamethoxazole-trimethoprim in the treatment of gonorrhoea. | |
| UA64212A (en) | Method for treating urogenital trichomoniasis in women | |
| Masson et al. | A mucosal barrier for topical HIV PrEP? | |
| RU2234924C1 (ru) | Способ лечения хронической хламидийной инфекции урогенитального тракта |